Selank 10mgMatch available documentation to the applicable research material and batch.
Royal Peptides products are offered exclusively for laboratory research, analytical, and scientific applications. Not for human or veterinary use.
Royal Peptides supplies compounds intended for controlled laboratory research and analytical applications.
Where applicable, Royal Peptides research materials are supplied in lyophilized form.
Lyophilization is a freeze-drying process used to remove moisture from material under controlled conditions.
Storage requirements may vary by compound, formulation, and production lot. Refer to the product label and available product-specific documentation.
Packaging components may vary slightly between production lots. This can include vial closures, cap styles, label positioning, and external packaging.
Selank is a synthetic heptapeptide research material derived from the tuftsin peptide sequence. It is studied in controlled experimental systems involving peptide signaling, molecular interactions, receptor-associated pathways, and neurobiological research models.
Not for human or veterinary use, administration, ingestion, injection, compounding, diagnostic, therapeutic, clinical, or personal use.
Selank is a synthetic seven-amino-acid peptide commonly described in scientific literature as a synthetic analogue derived from the naturally occurring tetrapeptide tuftsin.
Its defined peptide sequence provides a research material for laboratory investigation of structure-function relationships, peptide-associated molecular pathways, and experimentally measurable biochemical and cellular variables.
Royal Peptides supplies Selank strictly as a laboratory research material. References to published areas of investigation describe scientific context only and do not represent intended therapeutic or clinical uses of this product.
Selank is characterized by a defined seven-residue peptide sequence. Maintaining accurate compound and lot identification is important when incorporating the material into controlled analytical or experimental workflows.
Selank is structurally related to tuftsin, a naturally occurring tetrapeptide. The Selank sequence incorporates the tuftsin-related sequence within an extended seven-residue structure, providing a defined basis for comparative peptide research.
The seven-residue sequence provides a specific molecular identity for analytical characterization and controlled experimental work.
Selank's structural relationship to tuftsin provides a basis for comparative investigations involving peptide sequence and molecular behavior.
Laboratory models may examine relationships between the peptide's defined sequence and measurable molecular or biochemical variables.
Defined peptide materials can support controlled comparisons involving sequence, analytical characteristics, and experimental response variables.
Published experimental literature involving Selank spans several molecular and neurobiological research areas. These investigations use controlled laboratory models to study measurable mechanisms and should not be interpreted as intended uses of the research material sold on this page.
Experimental systems may examine Selank in relation to peptide-associated signaling pathways and measurable molecular responses.
Laboratory studies may investigate relationships between Selank and receptor-associated molecular systems under defined experimental conditions.
Selank appears in preclinical and laboratory literature involving neurobiological signaling and experimentally measurable molecular variables.
Controlled analytical models may characterize interactions involving Selank and selected molecular systems.
Laboratory evaluation should rely on analytical documentation associated with the specific Selank production lot under investigation. General product-page information should not replace applicable batch-specific records.
Appropriate laboratory records help maintain traceability between experimental observations and the specific Selank production lot incorporated into a research workflow.
Record the compound identity, stated material quantity, applicable production lot or batch reference, date received, and relevant internal laboratory identifier.
Preserve applicable analytical documentation, experimental observations, results, storage records, and other research records associated with the material.
Selank research material should be handled using appropriate laboratory procedures designed to preserve material identity, minimize contamination, and maintain experimental traceability.
Handle using appropriate laboratory practices and equipment. Maintain clear material identification throughout receipt, storage, analytical preparation, and experimental workflows.
Follow storage information associated with the applicable product label and batch documentation. Maintain appropriate laboratory storage and material-control records.
Royal Peptides Selank is supplied exclusively as a laboratory research material. It is not offered or represented as a medicine, pharmaceutical preparation, dietary supplement, food, cosmetic, or consumer health product.
Selank is a synthetic seven-amino-acid peptide derived from a tuftsin-related peptide sequence. Royal Peptides supplies it strictly as a laboratory research material.
Selank contains seven amino-acid residues and is therefore classified as a heptapeptide.
Selank is commonly identified by the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Researchers should rely on documentation corresponding to the specific material and production lot being evaluated.
Selank was developed as a synthetic peptide structurally related to tuftsin. This relationship provides a defined structural context for comparative laboratory research.
Published experimental research involving Selank includes peptide signaling, molecular interactions, receptor-associated pathways, and neurobiological research models. These are scientific research contexts, not intended uses of this product.
No. Royal Peptides supplies Selank strictly for laboratory research. It is not intended for human or veterinary administration.
No. Royal Peptides does not provide dosing, administration, injection, prescribing, treatment, or personal-use instructions for Selank.
Batch-specific analytical documentation corresponds to a particular production lot. Recording the applicable lot reference supports traceability between the research material, analytical documentation, and laboratory records.
Batch-specific analytical documentation may be available for the applicable production lot. Researchers should review documentation corresponding to the specific material received.
Selank is supplied for laboratory research use only. Not for human or veterinary use. Not intended for administration, ingestion, injection, personal experimentation, pharmaceutical compounding, pharmacy preparation, diagnostic use, therapeutic use, or clinical use. Nothing on this page constitutes medical advice or represents this research material as intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.
Product information pulled directly from WooCommerce.
Review available analytical documentation for the applicable product and batch.
View Analytical Documentation →Match available documentation to the applicable research material and batch.
Review the analytical information provided for the selected batch where available.
Keep relevant product and batch documentation with your research records.
Shipping options and delivery estimates are shown at checkout. Refer to the product label and applicable documentation for handling and storage information.
Complete payment using the available methods presented during checkout.
Tracking information is provided when available for the selected delivery service.
Use the product label and applicable documentation for handling and storage guidance.




Selank 10mg
Selank 10mg
PREMIUM RESEARCH MATERIALS
You must be at least 21 years old to enter. All products are intended strictly for laboratory research only — not for human or veterinary use or consumption.
INDEPENDENT RESEARCH • QUALITY • TRANSPARENCY
Verification remembered for 30 days